Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications.
Simbolo M, Centonze G, Giudice L, Grillo F, Maisonneuve P, Gkountakos A, Ciaparrone C, Cattaneo L, Sabella G, Giugno R, Bossi P, Spaggiari P, Del Gobbo A, Ferrero S, Mastracci L, Fabbri A, Filugelli M, Garzone G, Prinzi N, Pusceddu S, Testi A, Monti V, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: bria e. Cancers (Basel). 2022 Sep 24;14(19):4653. doi: 10.3390/cancers14194653. Cancers (Basel). 2022. PMID: 36230576 Free PMC article.
Adjuvant chemotherapy for non-small cell lung cancer.
Bria E, Cuppone F, Cecere FL, Milella M, Nisticò C, Cognetti F, Terzoli E. Bria E, et al. J Thorac Oncol. 2007 May;2(5 Suppl):S7-11. doi: 10.1097/01.JTO.0000268633.87529.75. J Thorac Oncol. 2007. PMID: 17457237 Free article. Review.
Sorafenib for lung cancer: is the "Battle" still open?
Bria E, Pilotto S, Tortora G. Bria E, et al. Expert Opin Investig Drugs. 2012 Oct;21(10):1445-8. doi: 10.1517/13543784.2012.707191. Epub 2012 Jul 16. Expert Opin Investig Drugs. 2012. PMID: 22799503
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
Pilotto S, Peretti U, Novello S, Rossi G, Milella M, Giaj Levra M, Ciuffreda L, Massari F, Brunelli M, Tortora G, Bria E. Pilotto S, et al. Among authors: bria e. Expert Opin Pharmacother. 2013 Apr;14(5):597-608. doi: 10.1517/14656566.2013.778828. Epub 2013 Mar 9. Expert Opin Pharmacother. 2013. PMID: 23472711 Review.
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.
Fassan M, Simbolo M, Bria E, Mafficini A, Pilotto S, Capelli P, Bencivenga M, Pecori S, Luchini C, Neves D, Turri G, Vicentini C, Montagna L, Tomezzoli A, Tortora G, Chilosi M, De Manzoni G, Scarpa A. Fassan M, et al. Among authors: bria e. Gastric Cancer. 2014;17(3):442-9. doi: 10.1007/s10120-013-0315-1. Epub 2013 Nov 23. Gastric Cancer. 2014. PMID: 24272205
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.
Pilotto S, Bria E, Peretti U, Massari F, Garassino M, Pelosi G, Tortora G. Pilotto S, et al. Among authors: bria e. J Thorac Oncol. 2013 Dec;8(12):e105-6. doi: 10.1097/JTO.0b013e3182a00e37. J Thorac Oncol. 2013. PMID: 24389444 Free article. No abstract available.
ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung.
Caliò A, Nottegar A, Gilioli E, Bria E, Pilotto S, Peretti U, Kinspergher S, Simionato F, Pedron S, Knuutila S, Tortora G, Eccher A, Santo A, Tondulli L, Inghirami G, Tabbò F, Martignoni G, Chilosi M, Scarpa A, Brunelli M. Caliò A, et al. Among authors: bria e. J Thorac Oncol. 2014 May;9(5):729-32. doi: 10.1097/JTO.0000000000000109. J Thorac Oncol. 2014. PMID: 24722159 Free article.
383 results